Efficacy and Safety of Quetiapine for Pediatric Bipolar Depression: A Systematic Review of Randomized Clinical Trials

Quetiapine is a second-generation antipsychotic (SGA) approved by the Food and Drug Administration (FDA) for the treatment of schizophrenia, mania, and aggression in children and adolescents. It is also commonly used as an off-label medication to treat children and adolescents with bipolar depressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivas, Sushma, Parvataneni, Tarun, Makani, Ramkrishna, Patel, Rikinkumar S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331915/
https://www.ncbi.nlm.nih.gov/pubmed/32637286
http://dx.doi.org/10.7759/cureus.8407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331915/
https://www.ncbi.nlm.nih.gov/pubmed/32637286
http://dx.doi.org/10.7759/cureus.8407

Ejemplares similares